PubRank

Suthat Fucharoen

Author PubWeight™ 95.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007 5.18
2 Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol Ther 2008 2.69
3 On T2* magnetic resonance and cardiac iron. Circulation 2011 2.33
4 Hemoglobin H disease: not necessarily a benign disorder. Blood 2002 1.91
5 A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E. Hum Genet 2010 1.75
6 T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol 2012 1.61
7 Targeted modification of a human beta-globin locus BAC clone using GET Recombination and an I-Scei counterselection cassette. Genomics 2003 1.58
8 Platelet inhibition by nitrite is dependent on erythrocytes and deoxygenation. PLoS One 2012 1.23
9 RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice. Proc Natl Acad Sci U S A 2009 1.21
10 International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 2010 1.14
11 Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder. Mol Ther 2002 1.11
12 A scoring system for the classification of beta-thalassemia/Hb E disease severity. Am J Hematol 2008 1.04
13 Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom 2004 1.03
14 Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 2002 1.03
15 Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides. Mol Pharmacol 2002 1.02
16 Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient. Stem Cells 2013 1.01
17 T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice. Eur J Haematol 2010 0.98
18 A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia. Genomics 2006 0.97
19 Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials. Blood Cells Mol Dis 2011 0.95
20 Activated platelet-derived microparticles in thalassaemia. Br J Haematol 2007 0.95
21 Fetal globin gene inducers: novel agents and new potential. Ann N Y Acad Sci 2010 0.95
22 Clinical trial of deferiprone iron chelation therapy in beta-thalassaemia/haemoglobin E patients in Thailand. Br J Haematol 2003 0.94
23 Prevalence and clinical significance of hepatitis C virus infection in Thai patients with thalassemia. Int J Hematol 2003 0.93
24 Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem 2009 0.93
25 Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. Am J Clin Nutr 2008 0.92
26 Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells. Am J Hematol 2009 0.92
27 UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers. Br J Clin Pharmacol 2008 0.90
28 Molecular analysis of beta-thalassemia in South Vietnam. Am J Hematol 2002 0.90
29 Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture. Ann Hematol 2006 0.90
30 Calibration of myocardial T2 and T1 against iron concentration. J Cardiovasc Magn Reson 2014 0.88
31 Early detection of cardiac involvement in thalassemia: From bench to bedside perspective. World J Cardiol 2013 0.88
32 Genetic modifiers in hemoglobinopathies. Curr Mol Med 2008 0.87
33 Increased erythropoiesis of beta-thalassaemia/Hb E proerythroblasts is mediated by high basal levels of ERK1/2 activation. Br J Haematol 2009 0.87
34 A humanized mouse model for a common beta0-thalassemia mutation. Genomics 2005 0.87
35 Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: comparison with levels in the lymphocytes of thalassemia patients. Int J Cancer 2009 0.87
36 Heart rate variability in beta-thalassemia patients. Eur J Haematol 2009 0.86
37 Increased oxidative metabolism is associated with erythroid precursor expansion in β0-thalassaemia/Hb E disease. Blood Cells Mol Dis 2011 0.86
38 BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7. Biochem Biophys Res Commun 2012 0.84
39 Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in beta-thalassemia. Redox Rep 2007 0.84
40 Enhanced activation of autophagy in β-thalassemia/Hb E erythroblasts during erythropoiesis. Ann Hematol 2011 0.84
41 Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients. Turk J Haematol 2015 0.84
42 Genetic modifiers of Hb E/beta0 thalassemia identified by a two-stage genome-wide association study. BMC Med Genet 2010 0.84
43 Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations. Hemoglobin 2007 0.84
44 Impaired bone formation and osteopenia in heterozygous β(IVSII-654) knockin thalassemic mice. Histochem Cell Biol 2011 0.84
45 In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients. Exp Hematol 2005 0.83
46 Association of SNP in exon 1 of HBS1L with hemoglobin F level in beta0-thalassemia/hemoglobin E. Int J Hematol 2008 0.83
47 Coinheritance of the different copy numbers of alpha-globin gene modifies severity of beta-thalassemia/Hb E disease. Ann Hematol 2007 0.83
48 Hemin: a possible cause of oxidative stress in blood circulation of beta-thalassemia/hemoglobin E disease. Free Radic Res 2003 0.83
49 Heart rate variability in beta-thalassemic mice. Int J Cardiol 2006 0.82
50 Increased urinary 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. Free Radic Biol Med 2008 0.82
51 Insertion of common mutations into the human beta-globin locus using GET Recombination and an EcoRI endonuclease counterselection cassette. J Biotechnol 2003 0.82
52 Cold exposure down-regulates zebrafish hematopoiesis. Biochem Biophys Res Commun 2010 0.82
53 A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease. Haematologica 2009 0.82
54 Insight into the peopling of Mainland Southeast Asia from Thai population genetic structure. PLoS One 2013 0.82
55 Differential plasma proteome profiles of mild versus severe β-thalassemia/Hb E. Ann Hematol 2012 0.81
56 Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients. J Proteomics 2012 0.81
57 Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status. Clin Pharmacokinet 2011 0.81
58 Expression of microRNA-451 in normal and thalassemic erythropoiesis. Ann Hematol 2010 0.81
59 Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice. Haematologica 2009 0.81
60 Genetic analysis of candidate modifier polymorphisms in Hb E-beta 0-thalassemia patients. Ann N Y Acad Sci 2005 0.80
61 Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice. Biometals 2012 0.80
62 Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload. Hemoglobin 2006 0.80
63 Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia/HbE. Pharmacology 2006 0.80
64 Comparison of pharmacokinetics and urinary iron excretion of two single doses of deferiprone in β-thalassemia/hemoglobin E patients. Pharmacology 2012 0.80
65 Calcium channels and iron uptake into the heart. World J Cardiol 2011 0.80
66 Cytokine-induced apoptosis of beta-thalassemia/hemoglobin E erythroid progenitor cells via nitric oxide-mediated process in vitro. Acta Haematol 2011 0.80
67 Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in beta-thalassemia. Free Radic Res 2009 0.79
68 In vitro antimicrobial activity of volatile organic compounds from Muscodor crispans against the pathogenic oomycete Pythium insidiosum. Southeast Asian J Trop Med Public Health 2012 0.79
69 Rapid diagnosis of alpha-thalassemia by melting curve analysis. J Mol Diagn 2010 0.79
70 Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. Blood Cells Mol Dis 2013 0.79
71 Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity. Br J Haematol 2011 0.79
72 Glutathione redox system in β -thalassemia/Hb E patients. ScientificWorldJournal 2013 0.79
73 An in vivo model for analysis of developmental erythropoiesis and globin gene regulation. FASEB J 2014 0.78
74 Molecular screening of the Hbs Constant Spring (codon 142, TAA>CAA, α2) and Paksé (codon 142, TAA>TAT, α2) mutations in Thailand. Hemoglobin 2010 0.78
75 The effects of vitamin E on platelet activity in beta-thalassaemia patients. Br J Haematol 2003 0.78
76 Rescued mice with Hb E transgene-developed red cell changes similar to human beta-thalassemia/HbE disease. Ann N Y Acad Sci 2005 0.78
77 Quantitative analysis of Hb Bart's in cord blood by capillary electrophoresis system. Ann Hematol 2010 0.78
78 Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients. Clin Chem Lab Med 2007 0.77
79 Proteomic analysis of hemoglobin H-constant spring (Hb H-CS) erythroblasts. Blood Cells Mol Dis 2011 0.77
80 Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system. Transl Res 2008 0.77
81 Molecular basis and hematological features of hemoglobin variants in Southern Thailand. Int J Hematol 2010 0.77
82 The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells. Int J Hematol 2003 0.77
83 Noninvasive prenatal diagnosis for hemoglobin Bart's hydrops fetalis. Int J Hematol 2005 0.77
84 Two cases of compound heterozygosity for Hb Hekinan [alpha27(B8)Glu-->Asp (alpha1)] and alpha-thalassemia in Thailand. Hemoglobin 2004 0.77
85 Genotypes and phenotypes of thalassemia: A discussion. Ann N Y Acad Sci 2005 0.77
86 Elevated F2-isoprostanes in thalassemic patients. Free Radic Biol Med 2007 0.77
87 Phenotypic characterization of circulating CD4/CD8 T-lymphocytes in β-thalassemia patients. Asian Pac J Allergy Immunol 2014 0.76
88 Characterisation of a novel oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-one. J Pharm Pharmacol 2015 0.76
89 Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and beta-thalassemia/Hb E with cholelithiasis. Eur J Haematol 2007 0.76
90 Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels. Drug Chem Toxicol 2012 0.76
91 Nitric oxide and caspase 3 mediated cytokine induced apoptosis in acute leukemia. Asian Pac J Allergy Immunol 2011 0.76
92 Hb Siam [alpha15(A13)Gly-->Arg (alpha1) (GGT-->CGT)] is a typical alpha chain hemoglobinopathy without an alpha-thalassemic effect. Hemoglobin 2002 0.76
93 Effect of coenzyme Q10 as an antioxidant in beta-thalassemia/Hb E patients. Biofactors 2005 0.76
94 Cardiomyocyte ultrastructural damage in β-thalassaemic mice. Int J Exp Pathol 2013 0.76
95 Role of interleukin-3 and signaling pathways on beta-thalassemia/HbE erythroid progenitor cell in culture. Southeast Asian J Trop Med Public Health 2007 0.76
96 Role of curcuminoids in ameliorating oxidative modification in β-thalassemia/Hb E plasma proteome. J Nutr Biochem 2012 0.76
97 Insertion of modifications in the beta-globin locus using GET recombination with single-stranded oligonucleotides and denatured PCR fragments. Mol Biotechnol 2003 0.75
98 Inhibition of alpha-globin gene expression by RNAi. Biochem Biophys Res Commun 2008 0.75
99 Correction: Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro. PLoS One 2016 0.75
100 A reduced curcuminoid analog as a novel inducer of fetal hemoglobin. Ann Hematol 2012 0.75
101 Clinical severity of β-thalassaemia/Hb E disease is associated with differential activities of the calpain-calpastatin proteolytic system. PLoS One 2012 0.75
102 The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in beta-thalassemia/Hb E. Clin Chem Lab Med 2006 0.75
103 Genetic polymorphisms and implications for human diseases. J Med Assoc Thai 2007 0.75
104 p53 and nitric oxide are involved in cytokine-induced apoptosis in Kasumi-1 and Molt-4 Leukemics cells. Asian Pac J Allergy Immunol 2014 0.75
105 Chicken egg yolk antibodies specific for the gamma chain of human hemoglobin for diagnosis of thalassemia. Int J Hematol 2006 0.75
106 Molecular mechanism of beta-thalassaemia caused by 22-bp duplication. Ann Hematol 2008 0.75
107 Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin. Int J Hematol 2006 0.75
108 Single nucleotide polymorphisms and haplotypes of protein C and protein S genes in the Thai population. Blood Coagul Fibrinolysis 2006 0.75
109 Phenotypic comparison of four thalassemia model mice reconstructed from cryo-banked embryos. Acta Biol Hung 2013 0.75
110 Modification of platelet shape change parameter by oxidized lipoprotein from beta-thalassemia/Hemoglobin E. J Med Assoc Thai 2009 0.75
111 Labdane diterpenes from the aerial parts of Curcuma comosa enhance fetal hemoglobin production in an erythroid cell line. J Nat Prod 2010 0.75
112 Report on the proceedings of the 15th International Conference on Oral Chelation (ICOC) in the Treatment of Thalassemia and Other Diseases at Taichung, Taiwan, April 22-26, 2005. Hemoglobin 2006 0.75
113 A pharmacokinetic study of paracetamol in Thai beta-thalassemia/HbE patients. Eur J Clin Pharmacol 2006 0.75
114 Double heterozygosity for Hb Pyrgos [beta83(EF7)Gly-->Asp] and Hb E [beta26(B8)Glu-->Lys] found in association with alpha-thalassemia. Hemoglobin 2002 0.75
115 Effect of human beta-globin bacterial artificial chromosome transgenesis on embryo cryopreservation in mouse models. Reprod Fertil Dev 2010 0.75
116 Hb Kodaira II [beta146(HC3)His --> Gln] detected in Thailand. Hemoglobin 2003 0.75
117 Hb Kurosaki [alpha7(A5)Lys -->Glu (AAG --> GAG)]: an alpha2-globin gene mutation found in Thailand. Hemoglobin 2005 0.75
118 Decreased nitrite levels in erythrocytes of children with β-thalassemia/hemoglobin E. Nitric Oxide 2013 0.75
119 Effects of Iron Chelators on Pulmonary Iron Overload and Oxidative Stress in β-Thalassemic Mice. Pharmacology 2015 0.75
120 Expression of betaE and gamma-globin genes in infants heterozygous for hemoglobin E and double heterozygous for hemoglobin E and alpha-thalassemia. Haematologica 2007 0.75
121 Platelet activation and platelet-leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis. Ann Hematol 2012 0.75
122 Lipid fluidity at different regions in LDL and HDL of beta-thalassemia/Hb E patients. Biochem Biophys Res Commun 2006 0.75
123 Characterization of a novel deletion causing (deltabeta)0-thalassemia in a Thai family. Am J Hematol 2007 0.75
124 Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. J Med Assoc Thai 2012 0.75
125 pHCR: a parallel haplotype configuration reduction algorithm for haplotype interaction analysis. J Hum Genet 2009 0.75